The Role of Right Atrial Ectopy Triggering Ganglionated Plexuses in AF

Recruiting N/A Interventional Study
Cardiac Arrhythmia Atrial Fibrillation
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 85
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
116 (estimated)
Sponsor
Imperial College London · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Atrial fibrillation (AF) is the most common rhythm disturbance of the heart. It can affect people of any age but usually happens as we get older. It can cause palpitations, breathlessness, lethargy, and fainting attacks. It is also associated with an increased risk of strokes. The best treatment for it at the moment involves burning or freezing (ablation) the heart muscle in a part of the heart c…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Males or females from 18 to 85yrs old * Symptomatic paroxysmal atrial fibrillation * Suitable candidate for catheter ablation * Signed informed consent Exclusion Criteria: * Contraindication to catheter ablation * Contraindication for general anaesthetic * Presence of a left…
Contacts

Jamie Kay, MBBS BMedSci

02033131000

jamie.kay@imperial.ac.uk

CONTACT